SEMMELWEIS UNIVERSITY, CENTRE FOR TRANSLATIONAL MEDICINE
TOPIC
The Biotechnological Improvements of Clinical Hemato-oncology
VISION
Provide new therapeutic solutions in hemato-oncology.
MISSION
Show the big picture of our current knowledge about a novel therapeutic option’s (CAR T cells) utility in clinical level.
SPECIFIC GOALS
- PROJECT 1: Comparing efficacy and toxicity of CAR T-cell versus conventional therapy in hemato-oncology: a systematic review and meta-analysis.
- PROJECT 2: Long-term effects of CAR T-cell treatment in hematological malignancies: a systematic review and meta-analysis.